Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476630 · ClinicalTrials.gov registry record
Thenar Tissue Oxygen Concentration (StO2): A Non-invasive Surrogate for Central Venous Oxygen Saturation (ScvO2)
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 69
- Enrollment target
NCT02476630 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 69 participants.
The verdict
NCT02476630 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
Oxygen concentration for patients undergoing cardiac catheterization and during admission to an intensive care unit is important outcome measure for clinical care. Currently, the tool used to monitor the oxygen concentration is a central venous access positioned in the superior vena cava or in the pulmonary artery to monitor the central venous oxygen saturation (ScvO2). However, it is invasive and not always possible due to a lack of a central line access. In this research study, the investigator would like use a noninvasive means for the ScvO2 by using the thenar tissue oxygen concentration (StO2). The primary aim for the study is to determine if the thenar StO2 correlates with ScvO2 and can serve as a noninvasive surrogate for ScvO2.
Interventions
- DEVICE StO2 measurement
- OTHER Blood Gases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02476630
The ClinicalTrials.gov registry entry for NCT02476630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which StO2 measurement is the first listed.
NCT02476630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02476630 about?
NCT02476630 is a clinical study titled "Thenar Tissue Oxygen Concentration (StO2): A Non-invasive Surrogate for Central Venous Oxygen Saturation (ScvO2)". Oxygen concentration for patients undergoing cardiac catheterization and during admission to an intensive care unit is important outcome measure for clinical care. Currently, the tool used to monitor the oxygen concentration is a central venous access positioned in the superior vena cava or in the p...
What is the current status of trial NCT02476630?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2015-07. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02476630?
The interventions under investigation include: StO2 measurement (DEVICE), Blood Gases (OTHER).
Who is sponsoring clinical trial NCT02476630?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.